Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271570 · ClinicalTrials.gov registry record · Phase 1
Infliximab (Remicade) for Patients With Acute Kawasaki Disease
A Phase 1 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00271570 is a Phase 1 study that has completed, run by University of California, San Diego. The registered enrollment target is 24 participants.
The verdict
NCT00271570, a Phase 1 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study evaluates the safety of infliximab in infants and children with acute Kawasaki Disease.
Interventions
- DRUG Infliximab (Remicade)
- BIOLOGICAL Intravenous immunoglobulin (IVIG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-04 |
| Est. Completion | 2006-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271570
The ClinicalTrials.gov registry entry for NCT00271570 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Infliximab (Remicade) is the first listed.
NCT00271570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00271570 about?
NCT00271570 is a clinical study titled "Infliximab (Remicade) for Patients With Acute Kawasaki Disease". This study evaluates the safety of infliximab in infants and children with acute Kawasaki Disease.
What is the current status of trial NCT00271570?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2004-04. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00271570?
The interventions under investigation include: Infliximab (Remicade) (DRUG), Intravenous immunoglobulin (IVIG) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00271570?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.